Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Praxis Precision Medicines (PRAX) Operating Expenses (2022 - 2025)

Praxis Precision Medicines has reported Operating Expenses over the past 4 years, most recently at $97.0 million for Q4 2025.

  • Quarterly results put Operating Expenses at $97.0 million for Q4 2025, up 35.88% from a year ago — trailing twelve months through Dec 2025 was $326.2 million (up 56.29% YoY), and the annual figure for FY2025 was $326.2 million, up 56.29%.
  • Operating Expenses for Q4 2025 was $97.0 million at Praxis Precision Medicines, up from $78.4 million in the prior quarter.
  • Over the last five years, Operating Expenses for PRAX hit a ceiling of $97.0 million in Q4 2025 and a floor of $26.0 million in Q3 2023.
  • Median Operating Expenses over the past 4 years was $50.7 million (2022), compared with a mean of $54.9 million.
  • Biggest five-year swings in Operating Expenses: plummeted 43.68% in 2023 and later skyrocketed 152.18% in 2024.
  • Praxis Precision Medicines' Operating Expenses stood at $41.5 million in 2022, then tumbled by 31.68% to $28.3 million in 2023, then skyrocketed by 152.18% to $71.4 million in 2024, then soared by 35.88% to $97.0 million in 2025.
  • The last three reported values for Operating Expenses were $97.0 million (Q4 2025), $78.4 million (Q3 2025), and $76.1 million (Q2 2025) per Business Quant data.